Category :

Medical Research Press Releases

Lotus Clinical Research Announces the Addition of Robert Dworkin, PhD as Director, Chronic Pain Research

Lotus Clinical Research Announces the Addition of Robert Dworkin, PhD as Director, Chronic Pain Research

Lotus Clinical Research, a specialty analgesic full-service CRO, has announced the addition of Robert (Bob) Dworkin, Ph.D. as Director of Chronic Pain Research. In his new role, Dr. Dworkin will lead Lotus’ current chronic pain research programs and work to…

Two Possible New Ways to Treat Silent Seizures in Children

Two Possible New Ways to Treat Silent Seizures in Children

As early as 3 months of age, infants with a severe form of epilepsy called Dravet syndrome start having convulsive seizures, during which their arms and legs jerk repeatedly. As they become toddlers, another type of seizure begins to appear.…

The American Academy of Stem Cell Physicians is Hosting a Cadaver and Live Workshop on January 26-27, 2019

The American Academy of Stem Cell Physicians is Hosting a Cadaver and Live Workshop on January 26-27, 2019

The American Academy of Stem Cell Physicians (AAOSCP) is hosting an upcoming Conference, Cadaver and Live Workshop on Jan. 26-27, 2019, at the Hyatt Regency in Miami, Florida. The event will feature two days of interactive workshops with small participant-to-instructor ratios with…

Lotus Clinical Research Adds Peggy Schrammel as Senior Vice President, CRO Services

Lotus Clinical Research Adds Peggy Schrammel as Senior Vice President, CRO Services

Lotus Clinical Research, a global specialty analgesic full-service CRO, announced the addition of Peggy Schrammel as Senior Vice President of CRO Services, which further builds its leadership team to address anticipated growth. Lotus Clinical Research remains committed to its mission of…

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment

Primate contract research organization Alpha Genesis today announced the second phase of its multi-year expansion effort, committing an additional $3M over the next two years towards new construction and hiring to further enhance the Company's product and service offerings. This announcement…

GABA-Receptor Modulation in the Treatment of Neurological Diseases

GABA-Receptor Modulation in the Treatment of Neurological Diseases

An article published in Experimental Biology and Medicine (Volume 243, Issue 13, September 2018)(https://journals.sagepub.com/doi/full/10.1177/1535370218800980) identifies new mechanisms that regulate the activity of the most common type of receptor in the mammalian brain, GABA receptors. The study, led by Dr. Sergiy Sylantyev in…

Development of Long-Acting Local Anesthetics

Development of Long-Acting Local Anesthetics

Lotus Clinical Research is pleased to announce that our Founder and Chief Executive Officer, Dr. Neil Singla, presented at the 12th annual Pain & Migraine Therapeutics Conference in San Francisco, California. Dr. Singla discussed "Development of Long-Acting Local Anesthetics: Clinical…

Phoenix Nest Inc. Licenses a Sanfilippo Syndrome Gene Therapy From the University of Manchester and is Preparing for a Clinical Trial

Phoenix Nest Inc. exclusively licensed a gene therapy for Sanfilippo syndrome (also known as Mucopolysaccharidosis IIIC, (MPSIIIC)) from The University of Manchester through its IP commercialization arm UMI3 Ltd. MPS IIIC is a devastating neurodegenerative lysosomal storage disorder of childhood…

Phoenix Nest Inc., Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and Washington University in St. Louis Announce a New NIH Grant for Sanfilippo Syndrome (MPSIIID)

The National Institute of Neurological Disorders and Stroke at the National Institutes of Health (NIH) recently awarded $5,612,276 in SBIR Phase IIB grant funding to Phoenix Nest, Inc., The Division of Medical Genetics at the Los Angeles Biomedical Research Institute…

Two Young Women Lung Cancer Investigators Receive $200k Research Grants From Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer

Two Young Women Lung Cancer Investigators Receive $200k Research Grants From Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer

Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC) have awarded a pair of two-year grants to support research that will help lung cancer patients lead longer, healthier lives. The grants were…

Bioelectronic Medicine: Using Electrical Stimulation to Treat Untreatable Diseases

Electrical stimulation of the human body is an established method of treating several diseases and conditions. Surgeons have been implanting artificial pacemakers and similar devices that electrically stimulate the heart since the 1960s for the treatment of diseases such as…

Applied Therapeutics to Present New Data on Novel Investigational Treatment for Galactosemia at 2018 NORD Summit

Applied Therapeutics Inc., a privately held biotechnology company focused on developing transformative drugs in areas of high unmet medical need, announced today that it will present data on AT-007, a novel investigational aldose reductase inhibitor, at the 2018 National Organization…

Vascular Stress Contributes to Age-Associated Vision Loss

An article published in Experimental Biology and Medicine (Volume 243, Issue 12, August, 2018 (http://journals.sagepub.com/doi/full/10.1177/1535370218794915) reports that vascular stress exacerbates age-associated vision loss. The study, led by Dr. Rajashekhar Gangaraju, in the Department of Ophthalmology and the Department of Anatomy…

$3.6 Million to Study Adverse Effects of Genome Editing

As genome editing technologies quickly advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. They are also bringing to light a number of challenges that need to be addressed before potential treatments can…

One Stem Cell Lab, Continues to Follow FDA Regulations of Minimally Manipulated Tissue and Explicitly Does NOT Manufacture, Distribute, the Use of Cord Blood (Hematic Stem Cells-HSC) in Any of One Stem Cell Lab's Products.

One Stem Cell Lab, continues to follow FDA regulations of minimally manipulated tissue and explicitly does NOT manufacture, distribute, the use of cord blood (Hematic Stem Cells-HSC) in any of One Stem Cell Lab’s  Products. One Stem Cell Lab is…

OccuPro Research Highlights the Success of OccuPro's Functional Capacity Evaluation

OccuPro, a company providing medical professionals and employers with the latest in functional capacity evaluation software and continuing education, is highlighting a 2018 publication titled “An evaluation of the inter-rater and intra-rater reliability of OccuPro’s functional capacity evaluation.” The publication…

International Symposium Convenes to Address Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders

With over 275 scientists, clinicians and patient organizations from around the world, The 2018 International Symposium on the Ehlers-Danlos Syndromes is bringing together the brightest minds in Ehlers-Danlos (EDS) research and clinical management to tackle some of the most pressing questions…

Metadichol – a Breakthrough in Diabetes Treatment From Nanorx Inc.

Diabetes is generally referred to by doctors as diabetes mellitus, which is a group of metabolic diseases in which the person has high levels of blood glucose (blood sugar) due to low levels of Insulin production by the pancreas or because the…

Genentech and Roche Welcomes Dr. Owen Garrick to the Steering Committee on Inclusive Research

Dr. Owen Garrick, CEO of Bridge Clinical Research, was invited to join Genentech and Roche’s Steering Committee on Inclusive Research.  “Genentech and Roche are committed to discovering and delivering medicines to treat patients with serious and life-threatening conditions. To continue…

FARE Clinical Network Adds Vanderbilt University Medical Center as New Center of Excellence

Food Allergy Research & Education (FARE) is pleased to announce today that Vanderbilt University Medical Center is joining the FARE Clinical Network, a food allergy research collaborative that now comprises 31 leading research and clinical care facilities across the country.…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login